Dual-Action Mechanism: Tirzepatide targets GLP-1 and GIP receptors, offering a unique and potentially more effective approach to weight management
Increase to 500 mcg on the second or third injection if tolerated
In a study of over 17,000 people, semaglutide, a GLP-1 receptor agonist medication, was found to lower the risk of cardiovascular events like heart attacks and strokes by 20% in people who have pre-existing cardiovascular disease and who are overweight, but do not have Type 2 diabetes
PlexusDx's Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required, making fertility-safe weight loss accessible to men planning families across diverse financial situations
Regular check-ins with your healthcare provider help ensure youre staying safe, managing your dosage correctly, and getting the most benefit from your treatment while supporting your long-term PCOS health